Barriers and facilitators to screening and assessment of functional status.

NIAID Data Ecosystem2026-05-01 收录

数据链接：

https://figshare.com/articles/dataset/Barriers_and_facilitators_to_screening_and_assessment_of_functional_status_/24028854 数据链接链接失效反馈

官方服务：

资源简介：

Barriers and facilitators to screening and assessment of functional status.

创建时间：

2023-08-24

Deep anterior lamellar keratoplasty versus penetrating keratoplasty: comparison of clinical outcomes in contralateral eyes

眼科手术

临床评估

ABSTRACT Purpose: This study aimed to compare the clinical outcomes following deep anterior lamellar keratoplasty and penetrating keratoplasty in contralateral eyes of the same patients. Methods: In t

DataCite Commons2023-07-18 更新30

Evalutation of the multidimensional assessement-tool RoBa (Ressource oriented analysis of demand) to gather the activity, nutrition and quality of life status of cancer patients

肿瘤支持性护理

临床评估

Interventions: Group 1: single assessment of all twelve tests of the RoBa-score shortly after primary cancer diagnosis Primary outcome(s): clinical feasibility of the RoBa-assessment as a whole with i

NIAID Data Ecosystem10

Supplementary Material for: In-Hospital Outcomes and Trends of Tricuspid Valve Surgery in Heart Transplant Patients

心脏移植术后三尖瓣手术

临床评估

Introduction: Tricuspid valve (TV) regurgitation is the most common valvular pathology after orthotopic heart transplant (OHT). The number of transplants being performed is increasing with patients li

Figshare2020-04-17 更新00

Means±SD, t-test results and ROC analysis results between infected (PCR+) and non-infected (PCR-) patients for COVID-19.

临床评估

ROC曲线分析

Parameters with best performance based on AUC comparisons after ROC analysis are presented in bold.

NIAID Data Ecosystem20

Dataset from A Phase III Multi-center, Open-label, Randomized Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

慢性髓性白血病

临床评估

In this study, the efficacy and safety of two nilotinib doses, 300 mg twice daily and 400 mg twice daily, were compared with imatinib 400 mg once daily in newly diagnosed patients with Philadelphia ch

NIAID Data Ecosystem00

Barriers and facilitators to screening and assessment of functional status.

资源简介：

相关数据集